Because ligandome analysis indicated that tumor cells presented the 10-mer, not the 9-mer, mCdt1 peptide on their H-2Kb molecules, we compared the reactivity of mCdt1-reactive CD8+ T cells to these 9-mer and 10-mer peptides. This evidence concerns the gene CD8A and neoplasm.